The global vascular stents market is projected to reach USD xx million in 2017 to USD XX till 2025 with a CAGR of XX %. The growth is majorly dominated by rising burden of coronary vascular diseases worldwide.
Other factors contributing the growth of vascular stents market include technological advancement, rise in aging population and accumulative rates of lifestyle diseases (diabetes and obesity). However, multiple product failures and growing regulatory approvals may slow down the market growth during the forecast period.
The vascular stents market is segmented based on product, type, stenting material used and mode of delivery. Product wise, vascular stent market is segmented into coronary stents, peripheral stents, neurovascular stents and others. Amongst these, the coronary vascular stents market is expected to witness the highest growth during the forecast period; additionally it accounted for the major share during 2017.
Region wise, the vascular stents market is spread across North America, Europe, Asia and Rest of the World. North America accounted for the largest market share in 2017 due to technological advancement and prevalence of obese population. Conversely, Asian market is anticipated to show the highest growth in the coming years due to rising adoption of advanced technologies, ever growing population and low manufacturing costs for medical devices.
The competitive landscape of the global vascular stents market is highly fragmented due to the presence of several big and new players. The major players include Medtroic, Inc., Boston Scientific Corporation, Abbott Laboratories, Terumo Europe NV, BIOTRONIK Schweiz AG, B. Braun Melsungen AG, Vascular Concept, W. L. Gore & Associates and others. Continuous innovation is a perpetual trend followed by these companies. Furthermore, huge investments are being made in research & development activities to improve the product offerings, with focus on developing 3-D, customized vascular stents which are biodegradable.
Key segments of the global vascular stents market
Product Overview, 2015-2025 (USD Million)
- Coronary Stents
- Peripheral Stents
- Neurovascular Stents
- Others
Material Overview, 2015-2025 (USD Million)
- Nitinol stents
- Cobalt chromium stents
- Platinum chromium stents
- Stainless steel stents
- Others
Type Overview, 2015-2025 (USD Million)
- Bare metal stents
- Drug eluting stents
- Bioresorbable stents
Mode of Delivery Overview, 2015-2025 (USD Million)
- Self-expanding stents
- Balloon expanding stents
Regional Overview, 2015-2025 (USD Million)
- North America
- Europe
- Asia Pacific
- Rest of the World (RoW)